Polar Capital Holdings’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.2M | Sell |
5,006,475
-1,700,000
| -25% | -$23.8M | 0.37% | 71 |
|
|
2025
Q1 | $105M | Sell |
6,706,475
-670,906
| -9% | -$10.5M | 0.64% | 45 |
|
|
2024
Q4 | $103M | Buy |
7,377,381
+493,009
| +7% | +$6.87M | 0.57% | 50 |
|
|
2024
Q3 | $64M | Buy |
6,884,372
+5,300
| +0.1% | +$49.3K | 0.31% | 69 |
|
|
2024
Q2 | $64M | Sell |
6,879,072
-6,850
| -0.1% | -$63.7K | 0.38% | 71 |
|
|
2024
Q1 | $68.2M | Buy |
6,885,922
+588,234
| +9% | +$5.83M | 0.36% | 70 |
|
|
2023
Q4 | $20.3M | Buy |
6,297,688
+3,179,744
| +102% | +$10.3M | 0.12% | 132 |
|
|
2023
Q3 | $16.6M | Sell |
3,117,944
-9,833
| -0.3% | -$52.2K | 0.12% | 150 |
|
|
2023
Q2 | $29.8M | Sell |
3,127,777
-7,736
| -0.2% | -$73.7K | 0.15% | 118 |
|
|
2023
Q1 | $34.5M | Buy |
3,135,513
+1,129,736
| +56% | +$12.4M | 0.22% | 107 |
|
|
2022
Q4 | $29.7M | Buy |
2,005,777
+696,509
| +53% | +$10.3M | 0.24% | 116 |
|
|
2022
Q3 | $25K | Sell |
1,309,268
-96,528
| -7% | -$1.85K | 0.16% | 122 |
|
|
2022
Q2 | $30K | Sell |
1,405,796
-378,209
| -21% | -$8.06K | 0.18% | 113 |
|
|
2022
Q1 | $34.4K | Hold |
1,784,005
| – | – | 0.16% | 117 |
|
|
2021
Q4 | $37K | Buy |
1,784,005
+235,104
| +15% | +$4.88K | 0.14% | 119 |
|
|
2021
Q3 | $37K | Sell |
1,548,901
-133,642
| -8% | -$3.19K | 0.15% | 117 |
|
|
2021
Q2 | $45.9K | Buy |
1,682,543
+125,000
| +8% | +$3.41K | 0.2% | 107 |
|
|
2021
Q1 | $45.1M | Buy |
1,557,543
+782,543
| +101% | +$22.6M | 0.28% | 94 |
|
|
2020
Q4 | $21.8M | Buy |
+775,000
| New | +$21.8M | 0.13% | 148 |
|